| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/14/2023 | 743.37% | JMP Securities | $8 → $7 | Maintains | Market Outperform |
| 09/19/2023 | 502.41% | Cantor Fitzgerald | → $5 | Reiterates | Overweight → Overweight |
| 09/18/2023 | 1586.75% | HC Wainwright & Co. | → $14 | Reiterates | Buy → Buy |
| 09/15/2023 | 863.86% | JMP Securities | → $8 | Reiterates | Market Outperform → Market Outperform |
| 06/28/2023 | 502.41% | Cantor Fitzgerald | $7 → $5 | Maintains | Overweight |
| 06/28/2023 | 1586.75% | HC Wainwright & Co. | → $14 | Reiterates | Buy → Buy |
| 05/19/2023 | 1948.19% | Canaccord Genuity | $16 → $17 | Maintains | Buy |
| 05/15/2023 | 1586.75% | HC Wainwright & Co. | $17 → $14 | Maintains | Buy |
| 03/28/2023 | 1948.19% | HC Wainwright & Co. | → $17 | Reiterates | → Buy |
| 02/14/2023 | 1948.19% | HC Wainwright & Co. | $21 → $17 | Maintains | Buy |
| 02/13/2023 | 863.86% | JMP Securities | → $8 | Reiterates | → Market Outperform |
| 09/12/2022 | 1225.3% | Jefferies | → $11 | Initiates Coverage On | → Buy |
| 08/02/2022 | 1948.19% | Canaccord Genuity | → $17 | Assumes | → Buy |
| 06/15/2022 | 984.34% | Cantor Fitzgerald | → $9 | Initiates Coverage On | → Overweight |
| 11/29/2021 | 1948.19% | Canaccord Genuity | $30 → $17 | Maintains | Buy |
| 11/15/2021 | 2068.67% | JMP Securities | $30 → $18 | Maintains | Market Outperform |
| 09/08/2021 | 2430.12% | Roth Capital | → $21 | Initiates Coverage On | → Buy |
| 05/27/2021 | 2912.05% | Oppenheimer | → $25 | Initiates Coverage On | → Outperform |
| 05/25/2021 | 2430.12% | HC Wainwright & Co. | → $21 | Initiates Coverage On | → Buy |
| 05/12/2021 | 3514.46% | Canaccord Genuity | $33 → $30 | Maintains | Buy |
| 10/14/2020 | 3514.46% | JMP Securities | $28 → $30 | Maintains | Market Outperform |
| 10/09/2019 | -33.73% | JMP Securities | → $0.55 | Initiates Coverage On | → Market Outperform |
| 09/09/2019 | -54.22% | Canaccord Genuity | → $0.38 | Initiates Coverage On | → Buy |
What is the target price for Rezolute (RZLT)?
The latest price target for Rezolute (NASDAQ: RZLT) was reported by JMP Securities on November 14, 2023. The analyst firm set a price target for $7.00 expecting RZLT to rise to within 12 months (a possible 743.37% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Rezolute (RZLT)?
The latest analyst rating for Rezolute (NASDAQ: RZLT) was provided by JMP Securities, and Rezolute maintained their market outperform rating.
When is the next analyst rating going to be posted or updated for Rezolute (RZLT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Rezolute, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Rezolute was filed on November 14, 2023 so you should expect the next rating to be made available sometime around November 14, 2024.
Is the Analyst Rating Rezolute (RZLT) correct?
While ratings are subjective and will change, the latest Rezolute (RZLT) rating was a maintained with a price target of $8.00 to $7.00. The current price Rezolute (RZLT) is trading at is $0.83, which is out of the analyst's predicted range.